WASHINGTON - The Clinical and Translational Science Institute at Children’s National (CTSI-CN), a partnership of Children’s National Medical Center and The George Washington University, has awarded more than $1 million in grants for 15 Pilot Studies projects, four Novel Clinical and Translational Methodologies projects, and two Mentored Career Development programs. These grants are given to promising young and junior researchers. This support is one way the CTSI-CN cultivates new talent and accelerates projects that show promise for future and in-depth investigations that have the potential to improve human health.
These grants are made possible with funding from the prestigious Clinical and Translational Science Award (CTSA) from the National Center for Research Resources of the National Institutes of Health (NIH) and Children’s National Medical Center. In July 2010, the CTSI-CN secured a CTSA grant of $20 million over five years. With the July grant, CTSI-CN joined the nationally renowned CTSA consortium, composed of nationally recognized research institutions that work to transform the local, regional, and national environment to increase the efficiency and speed of clinical and translational research across the country.
Many other CTSA member institutions engage in pediatric research, but the Children’s National/George Washington University collaboration is the first in the history of the award to focus specifically on how scientific breakthroughs from the laboratory bench can be brought more quickly and efficiently to the bedsides of young patients locally and around the world.
“The future health of this nation and of its families is dependent on what happens with today's children,” said Jill Joseph, MD, PhD, principal investigator of the CTSI-CN and Director of Center for Clinical and Community Research. “Protecting them from disease, promoting their health, and treating their illnesses are essential investments in our collective well being. We are pleased to support junior colleagues whose promising work we believe will advance our ability to prevent, understand, diagnose, and treat pediatric illness”
"These programs provide an unprecedented opportunity to encourage creative and innovative collaborations, launch new and innovative projects that will catalyze change between disciplines,” said Peter Hotez, MD, PhD, co-principal investigator of the CTSA, Distinguished Research Professor Walter G. Ross Professor and Chair and President of the Sabin Vaccine Institute. “These also will train a new cadre of physicians, scientists and health professionals at Children's National Medical Center and the George Washington University."
Related links:
